New Zealand markets close in 1 hour 28 minutes

Iovance Biotherapeutics, Inc. (IOVA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
10.68-0.04 (-0.37%)
At close: 04:00PM EDT
10.79 +0.11 (+1.02%)
After hours: 07:40PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
1,904
1,189
0
0
0
Cost of revenue
18,016
10,755
0
0
-
Gross profit
-16,112
-9,566
0
0
-
Operating expenses
Research development
341,126
344,077
294,781
259,039
201,727
Selling general and administrative
110,187
106,916
104,097
83,664
60,210
Total operating expenses
451,313
450,993
398,878
342,703
261,937
Operating income or loss
-467,425
-460,559
-398,878
-342,703
-261,937
Income before tax
-454,530
-447,516
-395,893
-342,252
-259,581
Income tax expense
-4,887
-3,479
0
0
-
Income from continuing operations
-449,643
-444,037
-395,893
-342,252
-259,581
Net income
-449,643
-444,037
-395,893
-342,252
-259,581
Net income available to common shareholders
-449,643
-444,037
-395,893
-342,252
-259,581
Basic EPS
-2.08
-1.89
-2.49
-2.23
-1.88
Diluted EPS
-2.08
-1.89
-2.49
-2.23
-1.88
Basic average shares
212,292
235,131
159,259
153,406
138,301
Diluted average shares
212,292
235,131
159,259
153,406
138,301